Design, synthesis, and biological evaluation with molecular dynamics study of novel pyrazolo[3,4- d ]pyrimidine derivatives as anti-cancer agents
Open Access
- 5 June 2023
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 13 (25) , 17074-17096
Abstract
Design strategy for pyrazolo[3,4- d ]pyrimidine derivatives based on tandutinib structure.Keywords
This publication has 38 references indexed in Scilit:
- Structure–Activity Relationship Studies of Pyrazolo[3,4-d]pyrimidine Derivatives Leading to the Discovery of a Novel Multikinase Inhibitor That Potently Inhibits FLT3 and VEGFR2 and Evaluation of Its Activity against Acute Myeloid Leukemia in Vitro and in VivoJournal of Medicinal Chemistry, 2013
- a-Anilinoketones, Esters and Amides: A Chemical StudyPharmaceuticals, 2012
- Synthesis and Anticonvulsant Activity of Some Novel 2-Methyl Imidazole DerivativesLetters in Drug Design & Discovery, 2012
- Synthesis, SAR and biological evaluation of 1,6-disubstituted-1H-pyrazolo[3,4-d]pyrimidines as dual inhibitors of Aurora kinases and CDK1Bioorganic & Medicinal Chemistry Letters, 2012
- Design, Synthesis, and Antitumor Evaluation of Novel Pyrazolo[3,4-d]pyrimidine DerivativesScientia Pharmaceutica, 2012
- Comparative analysis of human and bovine protein kinases reveals unique relationship and functional diversityGenetics and Molecular Biology, 2011
- Potent Activity of Ponatinib (AP24534) in Models of FLT3-Driven Acute Myeloid Leukemia and Other Hematologic MalignanciesMolecular Cancer Therapeutics, 2011
- Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivativesEuropean Journal of Medicinal Chemistry, 2010
- AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)Blood, 2009
- Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one Ring System as a Useful Template To Obtain Potent Adenosine Deaminase InhibitorsJournal of Medicinal Chemistry, 2009